Allergy and Anaphylaxis Australia (A&AA) is a charitable non-profit organisation that supports and assists Australians living with allergic disease including anaphylaxis.
In 2018, GSK assisted A&AA by providing financial support to the sum of $25,000 to:
Asthma Australia and member Foundations seek to eliminate asthma as a major cause of ill health and disruption within the community. They provide disease education, information, research, community advocacy and support to people with asthma and as well as their carers.
In 2018, GSK donated 1,182 Ellipta, 1,096 Accuhaler, 2,156 MDI, 426 Haleraid 120 and 411 Haleraid 200 placebo inhaler devices at an approximate cost of $20,306.
Lung Foundation Australia supports all aspects of lung health from asthma and COPD to pulmonary hypertension and cancer, providing community education and a toll-free patient information and support centre.
The organisation also supports research, develops educational fact-sheets, trains health professionals, and undertakes community awareness activity and advocacy around Australia.
In 2018, GSK supported a range of activities for the Lung Foundation Australia including:
Additionally, in 2018 GSK donated 3,000 Ellipta, 3,000 Accuhaler and 3,000 MDI placebo inhaler devices at an approximate cost of $40,350.
The Meningitis Centre Australia works towards raising public awareness for the signs and symptoms of meningitis and its various forms. The Centre lobbies for vaccines in Australia and works towards eliminating meningitis in Australia.
In 2018, GSK provided financial support (20,000) for costs associated with attendance and stall operations at five Pregnancy and Baby Expos across Australia (Adelaide, Sydney, Brisbane, Perth and Melbourne).
In addition, GSK provided an in-kind donation of Menveo and Bexsero vaccines for a family of 10 to the value of $4,100 (approximate value – the market costs of vaccines differ depending on retailer).
The National Asthma Council Australia is a not-for-profit organisation working to improve health outcomes and quality of life for people with asthma.
In 2018 GSK provided financial support to the sum of $72,700 for:
Additionally, in 2018 GSK donated 120 Ellipta, 170 Accuhaler and 170 MDI placebo inhaler devices at an approximate cost of $1,897.
The National Youth Science Forum (NYSF) brings together the best and brightest year 11 students from across the country to inspire and encourage the pursuit of scientific careers, from biology and medicine to earth science and engineering.
In 2018, GSK supported the NYSF with $20,000 to support the promotion and profile the pursuit of science and science-related careers among year 11 and 12 students around Australia. In addition, GSK presented during the NYSF Partner Day in Canberra and hosted 50 students in the Next Step holiday program at GSK’s manufacturing site in Boronia.
Pulmonary Hypertension Australia (PHAA) seeks to provide hope, support and education to their members as well as advocacy for the pulmonary hypertension community. The organisation is managed by an elected Board of Management - all volunteers - made up of patients, family members and friends who have been impacted by pulmonary hypertension.
In 2018, GSK supported PHAA Board of Management with $4,000 for their travel and accommodation costs, assisting PHAA to attend a ‘meet and greet’ session and conduct the PHAA Members and Carers Day session at PHSANZ ASM.
The Royal Institution of Australia (RiAus) is an independent charitable organisation dedicated to promoting public awareness and understanding of all things STEM. RiAus operates with the intention of making science not only enjoyable but also accessible to all Australians and looks to inspire STEM careers in the eyes of all young Australians.
In 2018, GSK provided financial support to RiAus to the sum of $35,000 to deliver 12 months of Body Channel content for Australia’s Science Channel’s platform.
Rural Aid is an Australian charity dedicated to supporting to drought, flood and fire affected rural communities.
In 2018, GSK donated $10,000 for the Australian Drought Relief Fund.
GSK has a longstanding partnership with Save the Children Australia. In 2018, GSK supported Save the Children with an independent charitable grant of $50,000 to support the running of ‘It Takes a Village’ program.
It Takes a Village (ITaV) supports the needs of migrant and refugee children, young people and families facing the challenges of starting a new life in Australia with little to no family support and often a history of trauma and loss. Funding supports various ITaV programs within metro and regional Victoria, including Shepparton and housing estates in Inner Melbourne.
GSK Australia has been a long-standing supporter of the Victoria Police Kokoda Project, supporting the initiative since it began in 2005. This initiative, designed to support disengaged youth and unites just over 40 local high school students, police officers and community members from around north west Melbourne through a four month intensive training program and nine day trek across Kokoda Track in Papua New Guinea.
In 2018, GSK provided $6,000 to support one student’s participation in the Kokoda Project and donation of necessary vaccinations to participants who require them, including students, police members, two MICA Flight Paramedics and other sponsors who support the program and mentor the students, to the value of $9,300 (approximate value).